UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2008, 3rd ed., ISBN 1934115258, 428
eBook
Ecancermedicalscience, ISSN 1754-6605, 06/2018, Volume 12, pp. 840 - 840
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 5, pp. 6028 - 6041
Journal Article
Annals of hematology, ISSN 0939-5555, 5/2019, Volume 98, Issue 5, pp. 1217 - 1224
Chemotherapy-induced neutropenia | Pegfilgrastim | Medicine & Public Health | Hematology | Oncology | Biosimilar | Febrile neutropenia | Life Sciences & Biomedicine | Science & Technology | Filgrastim - adverse effects | Biosimilar Pharmaceuticals - administration & dosage | Chemotherapy-Induced Febrile Neutropenia - epidemiology | Humans | Middle Aged | Chemotherapy-Induced Febrile Neutropenia - prevention & control | Polyethylene Glycols - adverse effects | Filgrastim - administration & dosage | Breast Neoplasms - drug therapy | Polyethylene Glycols - administration & dosage | Biosimilar Pharmaceuticals - adverse effects | Incidence | Adult | Female | Aged | Breast Neoplasms - epidemiology | Chemotherapy | Clinical trials | Drug therapy | Medicine, Preventive | Neutropenia | Cancer | Preventive health services | Index Medicus | Original
Journal Article
Blood, ISSN 0006-4971, 09/1996, Volume 88, Issue 6, pp. 1907 - 1929
Life Sciences & Biomedicine | Hematology | Science & Technology | Biological and medical sciences | Toxicity: blood | Medical sciences | Drug toxicity and drugs side effects treatment | Pharmacology. Drug treatments | Recombinant Proteins - therapeutic use | Lenograstim | Costs and Cost Analysis | Humans | Models, Molecular | Clinical Trials as Topic | Acquired Immunodeficiency Syndrome - drug therapy | Filgrastim | Neutropenia - drug therapy | Lymphoma - drug therapy | Animals | Hematopoiesis | Anemia, Aplastic - drug therapy | Granulocyte Colony-Stimulating Factor | Survival Analysis | Quality of Life | Mice | Myelodysplastic Syndromes - drug therapy | Index Medicus | Abridged Index Medicus | AIDS/HIV
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 50, pp. 83817 - 83827
Placental microenvironment | Materno-fetal tolerance | Carcinogenesis | Cancer microenvironment | Immune vigilance | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Immunohistochemistry | Breast Neoplasms - surgery | Pregnancy Complications - pathology | Tumor Escape - genetics | Breast Neoplasms - immunology | Humans | Pregnancy Complications - surgery | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Carcinoma, Lobular - genetics | Adult | Female | Carcinoma, Lobular - immunology | Carcinoma, Lobular - secondary | Carcinoma, Lobular - surgery | Placenta - immunology | Gene Expression Profiling - methods | Lymphatic Metastasis | Pregnancy | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Pregnancy Complications - genetics | Immune Tolerance - genetics | Biomarkers, Tumor - genetics | Biomarkers, Tumor - immunology | Pregnancy Complications - immunology | Index Medicus
Journal Article
Annals of hematology, ISSN 0939-5555, 9/2010, Volume 89, Issue 9, pp. 927 - 933
Medicine & Public Health | Hematology | Oncology | G-CSF | Filgrastim | Biosimilar | Neutropenia | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Male | Recombinant Proteins | Chemistry, Pharmaceutical | Cross-Over Studies | Young Adult | Granulocyte Colony-Stimulating Factor - pharmacokinetics | Adolescent | Adult | Female | Granulocyte Colony-Stimulating Factor - chemistry | Therapeutic Equivalency | Clinical trials | Product development | Macrophage colony stimulating factor | Granulocyte colony-stimulating factor | Pharmaceutical industry | Analysis | Index Medicus | Original
Journal Article
Annals of hematology, ISSN 0939-5555, 10/2010, Volume 89, Issue 10, pp. 971 - 978
Medicine & Public Health | Hematology | Oncology | G-CSF | Filgrastim | Biosimilar | Neutropenia | Life Sciences & Biomedicine | Science & Technology | Granulocyte Colony-Stimulating Factor - adverse effects | Area Under Curve | Humans | Middle Aged | Hematologic Diseases - drug therapy | Male | Recombinant Proteins | Granulocyte Colony-Stimulating Factor - therapeutic use | Neoplasms - drug therapy | Cross-Over Studies | Young Adult | Granulocyte Colony-Stimulating Factor - pharmacokinetics | Adolescent | Adult | Female | Therapeutic Equivalency | Clinical trials | Product development | Granulocyte colony-stimulating factor | Pharmaceutical industry | Comparative analysis | Index Medicus | Original
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 4564 - 4564
Journal Article
2000, ISBN 0896035816, xvi, 452
Book
2008, 3rd ed., ISBN 1934115258
Web Resource
2008, 3rd ed., ISBN 9781597454704
Web Resource
2004, 2nd ed., ISBN 9781592596645
Web Resource
2004, 2nd ed., ISBN 9781592596645
Web Resource
2004, 2nd ed., ISBN 9781592596645
Web Resource
18.
Full Text
HER2 Blockade in Metastatic Collecting Duct Carcinoma (CDC) of the Kidney: A Case Report
Oncology research and treatment, ISSN 2296-5270, 12/2012, Volume 35, Issue 12, pp. 776 - 779
Case Report · Kasuistik | Bellini's tumor | Double HER2 blockade | Lapatinib | Trastuzumab | Collecting duct carcinoma (CDC) | Life Sciences & Biomedicine | Oncology | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Fluorouracil - analogs & derivatives | Administration, Oral | Capecitabine | Carcinoma, Renal Cell - pathology | Deoxycytidine - administration & dosage | Humans | Male | Treatment Outcome | Brain Neoplasms - prevention & control | Brain Neoplasms - secondary | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Carcinoma, Renal Cell - secondary | Kidney Neoplasms - pathology | Quinazolines - administration & dosage | Aged | Receptor, ErbB-2 - antagonists & inhibitors | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives
Journal Article
19.
Full Text
Can hematopoietic growth factors be used to improve the success of cytotoxic chemotherapy?
Anti-cancer drugs, ISSN 0959-4973, 04/1993, Volume 4, Issue 2, pp. 127 - 140
hematopoietic growth factors | GM-CSF | G-CSF | HGF | high-dose chemotherapy | Pharmacology & Pharmacy | Oncology | Life Sciences & Biomedicine | Science & Technology | Dose-Response Relationship, Drug | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Growth Substances - therapeutic use | Humans | Neoplasms - physiopathology | Neoplasms - drug therapy | Index Medicus
Journal Article